Verras has launched a new tool to help physicians identify, understand and implement solutions for clinical variation. The tool, called Verras Watson, is an extension of the company’s Verras Sherlock, ...
Comprehensive genomic profiling (CGP) in post-systemic treatment (Post) metastatic sites (MET) and pretreatment (Pre) primary tumors (PT) of metastatic prostate cancer (mPC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback